DAVID COX: Open Payments
NPI 1841471604 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 80 payments from 17 companies in 2025. Trend: 2023 $924 · 2024 $423 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $238 |
| Novo Nordisk Inc | 14 | $226 |
| PFIZER INC. | 14 | $193 |
| Lilly USA, LLC | 11 | $171 |
| GlaxoSmithKline, LLC. | 11 | $155 |
| Phathom Pharmaceuticals, Inc. | 6 | $124 |
| Exact Sciences Corporation | 5 | $79 |
| Dexcom, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| ABBVIE INC. | 2 | $50 |
Products named: FARXIGA, MOUNJARO, NURTEC ODT, TRELEGY ELLIPTA, VOQUEZNA, Ozempic, Cologuard Collection Kit, Rybelsus.
Industry payments across TX — which companies pay providers there.
